RXRX
#2084
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.3 4 USD
+0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.21%
Variación mensual
+2.14%
Variación en los últimos 6 meses
-28.17%
Cambio anual
-36.86%
Cierres anteriores
3.3 0
Open
3.3 4
Mínimo
3.3 4
High
3.3 4
Volumen
158
Financials
- Market Capitalization 1.77 B
- Employee 600
- Founded 2013
- CEO Najat Khan
- Website www.recursion.com
- Headquarter Delaware, United States
- FIGI BBG00PQ4XJ45
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.65
Relación precio/flujo de caja
20.56
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2071 |  ZYME Zymeworks Inc. - Common Stock | 24.66 USD | -1.12% | -7.36% | +5.84% | +39.01% | 1.80 B USD | ||
| 2072 |  AAPG Ascentage Pharma Group International - American Depository Shar | 19.24 USD | -1.94% | +4.96% | +13.11% | -23.04% | 1.80 B USD | ||
| 2095 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 3.93 USD | -2.72% | -9.03% | -2.72% | +103.63% | 1.75 B USD | ||
| 2106 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 37.91 USD | +3.66% | +3.18% | +35.54% | +99.53% | 1.72 B USD |